Hanson McClain Advisors »

Beam Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.7k 204 33.04
2023-12-31 $15k 566 27.22
2023-09-30 $27k 1.1k 24.05
2023-06-30 $13k 419 31.93
2023-03-31 $11k 362 30.62
2022-12-31 $15k 392 39.11
2022-09-30 $19k 395 48.10
2022-06-30 $18k 465 38.71
2022-03-31 $27k 465 58.06
2021-12-31 $32k 402 79.60
2021-09-30 $35k 402 87.06
2021-06-30 $52k 402 129.35
2021-03-31 $48k 602 79.73
2020-12-31 $38k 462 82.25
2020-09-30 $5.0k 220 22.73